Patent · US Active

Agmatine compositions for treatment of osteoarthritis

US11622949B1 · kind B1 · utility

0Cited by
8References
20Claims
0Family size

Inventors

Key dates

Filing dateAug 4, 2022
Grant dateApr 11, 2023
Priority date—
Expiry dateAug 4, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Dietary supplements, nutraceutical compositions, medical foods, animal feeds, and pharmaceutical compositions for treating osteoarthritis and other osteo-articular conditions involving neuropathy and associated symptoms. A synergistic composition containing a high dose range of agmatine and acceptable salts thereof and in combination with other active ingredients having salutary effects in treating osteoarthritis and other osteo-articular conditions involving neuropathy and associated symptoms. The composition prepared with excipients and compatible carriers, including but not limited to, powders, tablets, capsules, controlled release carriers, lozenges and chewable preparations, liquid suspensions, suspensions in an edible supporting matrix or foodstuff and oral rehydration solution to facilitate consumption.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.